1276119
Last Update Posted: 2012-03-22
Recruiting has ended
Males accepted | 18 Years-60 Years |
67 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males
To evaluate the safety, tolerability, blood levels and effects of CDP6038 administered by intravenous infusion (iv) and subcutaneous (sc) injection.
Eligibility
Relevant conditions:
Pharmacokinetics
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov